US CRO contracted by FDA to answer generics safety questions
CRO Vince & Associated Clinical Research (VACR) has won a $5m grant to conduct bioequivalence studies for the US FDA.
Archives for September 25, 2012
update
SNBL adopts new temp and humidity control system
Preclinical CRO SNBL USA has automated control of temperature and humidity at its primate research laboratory.
Big Pharma clinical R&D group wants FDA and EMA involvement
Big Pharma group TransCelerate BioPharma plans to work with regulators and academics to address the bottlenecks that slow the clinical development of biologic drugs.
Thermo Fisher targets Eastern Europe’s pharmas with new R&D site
Thermo Fisher Scientific has set up a unit for molecular biology techs at its site in Lithuania, citing pharmaceutical R&D labs in Eastern Europe as a target.
Cedarburg Hauser boosts API production capacity
Cedarburg Hauser Pharmaceuticals (CHP) has increased its API plant in a bid to meet client demand.
Could oral testosterone replacement therapy come in a capsule?
Clarus Therapeutics believes it has solved the oral availability problem for testosterone replacement therapy.